|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 151 - 180 of 254 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Rivaroxaban Orion 10 mg tabletti, kalvopäällysteinen SPC 2023-08-25
|
|
PL
|
Resepti
|
Rivaroxaban Orion 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2023-11-10
|
|
PL
|
Resepti
|
Rivaroxaban Orion 2.5 mg tabletti, kalvopäällysteinen SPC 2023-08-25
|
|
PL
|
Resepti
|
Rivaroxaban ratiopharm 10 mg tabletti, kalvopäällysteinen SPC 2023-12-20
|
|
PL
|
Resepti
|
Rivaroxaban ratiopharm 15 mg tabletti, kalvopäällysteinen SPC 2023-12-20
|
|
PL
|
Resepti
|
Rivaroxaban ratiopharm 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2023-12-20 aloituspakkaus
|
|
PL
|
Resepti
|
Rivaroxaban ratiopharm 2,5 mg tabletti, kalvopäällysteinen SPC 2023-12-20
|
|
PL
|
Resepti
|
Rivaroxaban ratiopharm 20 mg tabletti, kalvopäällysteinen SPC 2023-12-20
|
|
PL
|
Resepti
|
Rivaroxaban Sandoz 10 mg tabletti, kalvopäällysteinen SPC 2024-04-02
|
|
PL
|
Resepti
|
Rivaroxaban Sandoz 15 mg tabletti, kalvopäällysteinen SPC 2024-04-02
|
|
PL
|
Resepti
|
Rivaroxaban Sandoz 2,5 mg tabletti, kalvopäällysteinen SPC 2024-04-02
|
|
PL
|
Resepti
|
Rivaroxaban Sandoz 20 mg tabletti, kalvopäällysteinen SPC 2024-04-02
|
|
PL
|
Resepti
|
Rivaroxaban Stada 10 mg tabletti, kalvopäällysteinen SPC 2023-08-23
|
|
PL
|
Resepti
|
Rivaroxaban Stada 15 mg + 20 mg tabletti, kalvopäällysteinen SPC 2023-08-23
|
|
PL
|
Resepti
|
Rivaroxaban Stada 15 mg kapseli, kova SPC 2024-04-08
|
|
PL
|
Resepti
|
Rivaroxaban Stada 15 mg tabletti, kalvopäällysteinen SPC 2023-08-23
|
|
PL
|
Resepti
|
Rivaroxaban Stada 15 mg, 20 mg kapseli, kova hoidon aloituspakkaus SPC 2024-04-08
|
|
PL
|
Resepti
|
Rivaroxaban Stada 2,5 mg tabletti, kalvopäällysteinen SPC 2023-08-23
|
|
PL
|
Resepti
|
Rivaroxaban Stada 20 mg kapseli, kova SPC 2024-04-08
|
|
PL
|
Resepti
|
Rivaroxaban Stada 20 mg tabletti, kalvopäällysteinen SPC 2023-08-23
|
|
|
|
European Medicines Agency's website:
Rivaroxaban Viatris (ent. Rivaroxaban Mylan) - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Rivastigmin Orion 1,5 mg, 3 mg, 4,5 mg, 6 mg kapseli, kova SPC 2023-07-04
|
|
|
|
European Medicines Agency's website:
Rivastigmine 1 A Pharma - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Rivastigmine Actavis - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Rivastigmine Hexal - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Rivastigmine Sandoz - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Rivastor 13.3 mg-24 tuntia depotlaastari SPC 2021-06-04
|
|
PL
|
Resepti
|
Rivastor 4.6 mg-24 tuntia, 9.5 mg-24 tuntia depotlaastari SPC 2020-02-26
|
|
PL
|
Resepti
|
Rivatril 0,5 mg, 2 mg tabletti SPC 2022-02-02
|
|
PL
|
Resepti
|
Rivaxa 10 mg tabletti, kalvopäällysteinen SPC 2024-03-15.docx
|
|
|
| |
